CLN5 deficiency results in alterations in the activation of autophagy

Master of Science === Department of Biology === Stella Y. Lee === CLN5 is one of several proteins that when mutated result in the lysosomal storage disorder (LSD) Neuronal Ceroid Lipofuscinosis (NCL). CLN5 is a soluble lysosomal protein that has no known function at this time. Previously we showed t...

Full description

Bibliographic Details
Main Author: Budden, Theodore
Language:en_US
Published: Kansas State University 2015
Subjects:
Online Access:http://hdl.handle.net/2097/20473
id ndltd-KSU-oai-krex.k-state.edu-2097-20473
record_format oai_dc
spelling ndltd-KSU-oai-krex.k-state.edu-2097-204732018-07-22T03:45:31Z CLN5 deficiency results in alterations in the activation of autophagy Budden, Theodore Lysosomal storage disorder Autophagy Neuronal ceroid lipofuscinoses CLN5 Biology (0306) Master of Science Department of Biology Stella Y. Lee CLN5 is one of several proteins that when mutated result in the lysosomal storage disorder (LSD) Neuronal Ceroid Lipofuscinosis (NCL). CLN5 is a soluble lysosomal protein that has no known function at this time. Previously we showed that eight asparagine residues in CLN5 are N-glycosylated, and that this modification is important for the protein’s transport and function. Now, we have identified a link between the activation of autophagy and CLN5 deficiency. The autophagy-lysosomal protein degradation system is one of the major pathways the cell uses to degrade intracellular material and recycle cellular building blocks. It was recently shown that other CLN proteins affect the relative level of autophagy, indicating a potential link between the autophagy pathway and the NCLs. By knocking down endogenous CLN5 in HeLa we showed that, upon stress induction, cells responded with higher levels of autophagy activation. Consistent with these knockdown experiments, there is a higher level of the autophagy marker protein, LC3-II, in CLN5 patient cells that are naturally deficient for the CLN5 protein. Pharmaceutical induction of autophagy through different means also showed higher LC3-II levels compared to control, though patterns differed in the type of autophagy induced. In summary, we discovered that the autophagy pathway is altered in CLN5 deficient cells, indicating a potential role for CLN5 in autophagy. Further analyses of the autophagy pathway will shed light on where CLN5 is acting and the mechanism by which defective CLN5 causes NCL. 2015-10-12T18:23:09Z 2015-10-12T18:23:09Z 2014-08-01 2014 August Thesis http://hdl.handle.net/2097/20473 en_US Kansas State University
collection NDLTD
language en_US
sources NDLTD
topic Lysosomal storage disorder
Autophagy
Neuronal ceroid lipofuscinoses
CLN5
Biology (0306)
spellingShingle Lysosomal storage disorder
Autophagy
Neuronal ceroid lipofuscinoses
CLN5
Biology (0306)
Budden, Theodore
CLN5 deficiency results in alterations in the activation of autophagy
description Master of Science === Department of Biology === Stella Y. Lee === CLN5 is one of several proteins that when mutated result in the lysosomal storage disorder (LSD) Neuronal Ceroid Lipofuscinosis (NCL). CLN5 is a soluble lysosomal protein that has no known function at this time. Previously we showed that eight asparagine residues in CLN5 are N-glycosylated, and that this modification is important for the protein’s transport and function. Now, we have identified a link between the activation of autophagy and CLN5 deficiency. The autophagy-lysosomal protein degradation system is one of the major pathways the cell uses to degrade intracellular material and recycle cellular building blocks. It was recently shown that other CLN proteins affect the relative level of autophagy, indicating a potential link between the autophagy pathway and the NCLs. By knocking down endogenous CLN5 in HeLa we showed that, upon stress induction, cells responded with higher levels of autophagy activation. Consistent with these knockdown experiments, there is a higher level of the autophagy marker protein, LC3-II, in CLN5 patient cells that are naturally deficient for the CLN5 protein. Pharmaceutical induction of autophagy through different means also showed higher LC3-II levels compared to control, though patterns differed in the type of autophagy induced. In summary, we discovered that the autophagy pathway is altered in CLN5 deficient cells, indicating a potential role for CLN5 in autophagy. Further analyses of the autophagy pathway will shed light on where CLN5 is acting and the mechanism by which defective CLN5 causes NCL.
author Budden, Theodore
author_facet Budden, Theodore
author_sort Budden, Theodore
title CLN5 deficiency results in alterations in the activation of autophagy
title_short CLN5 deficiency results in alterations in the activation of autophagy
title_full CLN5 deficiency results in alterations in the activation of autophagy
title_fullStr CLN5 deficiency results in alterations in the activation of autophagy
title_full_unstemmed CLN5 deficiency results in alterations in the activation of autophagy
title_sort cln5 deficiency results in alterations in the activation of autophagy
publisher Kansas State University
publishDate 2015
url http://hdl.handle.net/2097/20473
work_keys_str_mv AT buddentheodore cln5deficiencyresultsinalterationsintheactivationofautophagy
_version_ 1718713246124343296